Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease

E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk-Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science